The 5th International Society for Stem Cell Research (ISSCR) Annual Meeting, June 2007

Stem Cells

Volumn 26, Issue 1, 2008, Pages 292-298

  Rajasekhar, Vinagolu K ^a   Dalerba, Piero ^b   Passegué, Emmanuelle ^c   Lagasse, Eric ^d   Najbauer, Joseph ^e  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Aberrant differentiation; Adult stem cells; Cancer stem cells; Epigenetic alterations; Glioblastoma hematopoietic stem cells; Metastasis; Polycomb group proteins; Self renewal; Stem cell maintenance stem cell niche; Tumor microenvironment; Tumor stroma

Indexed keywords

CANCER GROWTH; CANCER STEM CELL; CARCINOGENESIS; CARCINOGENIC ACTIVITY; CELL DIFFERENTIATION; CELL POPULATION; CONFERENCE PAPER; CYTOLOGY; EPIGENETICS; HUMAN; MEDICAL RESEARCH; METASTASIS; MICROENVIRONMENT; SIGNAL TRANSDUCTION; STEM CELL; TUMOR GROWTH;

ADULT STEM CELLS; ANIMALS; EPIGENESIS, GENETIC; HUMANS; NEOPLASTIC STEM CELLS;

EID: 38349074508     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2007-0647     Document Type: Conference Paper

References (52)

1. Moore KA, Lemischka IR. Stem cells and their niches. Science 2006;311:1880-1885.
2. Clarke MF, Fuller M. Stem cells and cancer: Two faces of eve. Cell 2006;124:1111-1115.
3. Rajasekhar VK. Analytical methods for cancer stem cells. In: Vemuri MC, ed. Stem Cell Assays. Totowa, NJ: Humana Press 2007:83-94.
4. Orkin SH, Pera M. Stem Cells Down Under - ISSCR 2007. Cell Stem Cell 2007;1:271-276.
5. Wang JC, Dick JE. Cancer stem cells: Lessons from leukemia. Trends Cell Biol 2005;15:494-501.
6. Guzman ML, Swiderski CF, Howard DS et al. Preferential induction of apoptosis for primary human leukemic stem cells. Proc Natl Acad Sci U S A 2002;99:16220-16225.
7. Bao S, Wu Q, McLendon RE et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006;444:756-760.
8. Reya T, Morrison SJ, Clarke MF et al. Stem cells, cancer, and cancer stem cells. Nature 2001;414:105-111.
9. Barnhart BC, Simon MC. Metastasis and stem cell pathways. Cancer Metastasis Reviews 2007;26:261-271.
10. Tlsty TD, Hein PW. Know thy neighbor: Stromal cells can contribute oncogenic signals. Curr Opin Genet Dev 2001;11:54-59.
11. Dalerba P, Dylla SJ, Park IK et al. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA 2007;104:10158-10163.
12. Dalerba P, Clarke MF. Cancer stem cells and tumor metastasis: First steps into uncharted territory. Cell Stem Cell 2007;1:241-242.
13. Kim I, Saunders TL, Morrison SJ. Sox17 dependence distinguishes the transcriptional regulation of fetal from adult hematopoietic stem cells. Cell 2007;130:470-483.
14. Nakagawa T, Nabeshima Y, Yoshida S. Functional identification of the actual and potential stem cell compartments in mouse spermatogenesis. Dev Cell 2007;12:195-206.
15. Zhu Y, Parada LF. The molecular and genetic basis of neurological tumours. Nat Rev Cancer 2002;2:616-626.
16. Sanai N, Alvarez-Buylla A, Berger MS. Neural stem cells and the origin of gliomas. N Engl J Med 2005;353:811-822.
17. Gilbertson RJ, Rich JN. Making a tumour's bed: Glioblastoma stem cells and the vascular niche. Nat Rev Cancer 2007;7:733-736.
18. Cotsarelis G, Sun TT, Lavker RM. Label-retaining cells reside in the bulge area of pilosebaceous unit: Implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell 1990;61:1329-1337.
19. Fuchs E. Scratching the surface of skin development. Nature 2007;445:834-842.
20. Kobielak K, Stokes N, de la Cruz J et al. Loss of a quiescent niche but not follicle stem cells in the absence of bone morphogenetic protein signaling. Proc Natl Acad Sci U S A 2007;104:10063-10068.
21. Laconi E. The evolving concept of tumor microenvironments. Bioessays 2007;29:738-744.
22. Waddington CH. Cancer and the theory of organizers. Nature 1935;135:606-608.
23. Mintz B, Illmensee K. Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc Natl Acad Sci U S A 1975;72:3585-3589.
24. Moinfar F, Man YG, Arnould L et al. Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: Implications for tumorigenesis. Cancer Res 2000;60:2562-2566.
25. Weber F, Shen L, Fukino K et al. Total-genome analysis of BRCA1/2-related invasive carcinomas of the breast identifies tumor stroma as potential landscaper for neoplastic initiation. Am J Hum Genet 2006;78:961-972.
26. Kuperwasser C, Chavarria T, Wu M et al. Reconstruction of functionally normal and malignant human breast tissues in mice. Proc Natl Acad Sci U S A 2004;101:4966-4971.
27. Lopez-Otin C, Matrisian LM. Emerging roles of proteases in tumour suppression. Nat Rev Cancer 2007;7:800-808.
28. Maffini MV, Soto AM, Calabro JM et al. The stroma as a crucial target in rat mammary gland carcinogenesis. J Cell Sci 2004;117:1495-1502.
29. Littlepage LE, Egeblad M, Werb Z. Coevolution of cancer and stromal cellular responses. Cancer Cell 2005;7:499-500.
30. Passegue E, Wagner EF, Weissman IL. JunB deficiency leads to a myeloproliferative disorder arising from hematopoietic stem cells. Cell 2004;119:431-443.
31. Walkley CR, Shea JM, Sims NA et al. Rb regulates interactions between hematopoietic stem cells and their bone marrow microenvironment. Cell 2007;129:1081-1095.
32. Le LQ, Parada LF. Tumor microenvironment and neurofibromatosis type I: Connecting the GAPs. Oncogene 2007;26:4609-4616.
33. Schuettengruber B, Chourrout D, Vervoort M et al. Genome regulation by polycomb and trithorax proteins. Cell 2007;128:735-745.
34. Bernstein BE, Meissner A, Lander ES. The mammalian epigenome. Cell 2007;128:669-681.
35. Sparmann A, van Lohuizen M. Polycomb silencers control cell fate, development and cancer. Nat Rev Cancer 2006;6:846-856.
36. Rajasekhar VK, Begemann M. Roles of polycomb group proteins in development and disease: A stem cell perspective. Stem Cells 2007;25:2498-2510.
37. Ohm JE, Baylin SB. Stem cell chromatin patterns: An instructive mechanism for DNA hypermethylation? Cell Cycle 2007;6:1040-1043.
38. Haupt Y, Alexander WS, Barri G et al. Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in E mu-myc transgenic mice. Cell 1991;65:753-763.
39. van Lohuizen M, Verbeek S, Scheijen B et al. Identification of cooperating oncogenes in E mu-myc transgenic mice by provirus tagging. Cell 1991;65:737-752.
40. Park IK, Morrison SJ, Clarke MF. Bmi1, stem cells, and senescence regulation. J Clin Invest 2004;113:175-179.
41. Molofsky AV, Pardal R, Iwashita T et al. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 2003;425:962-967.
42. Lessard J, Sauvageau G. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 2003;423:255-260.
43. Iwama A, Oguro H, Negishi M et al. Enhanced self-renewal of hematopoietic stem cells mediated by the polycomb gene product Bmi-1. Immunity 2004;21:843-851.
44. Leung C, Lingbeek M, Shakhova O et al. Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas. Nature 2004;428:337-341.
45. Bruggeman SW, Hulsman D, Tanger E, et al. Bmi1 controls tumor development in an Ink4a/Arf-independent manner in a mouse model for glioma. Cancer Cell 2007;12:328-341.
46. Hu M, Yao J, Cai L et al. Distinct epigenetic changes in the stromal cells of breast cancers. Nat Genet 2005;37:899-905.
47. Bernards R, Weinberg RA. A progression puzzle. Nature 2002;418:823.
48. Nguyen DX, Massague J. Genetic determinants of cancer metastasis. Nat Rev Genet 2007;8:341-352.
49. Li F, Tiede B, Massague J et al. Beyond tumorigenesis: Cancer stem cells in metastasis. Cell Res 2007;17:3-14.
50. Fan X, Matsui W, Khaki L et al. Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. Cancer Res 2006;66:7445-7452.
51. Konopleva M, Andreeff M. Targeting the leukemia microenvironment. Curr Drug Targets 2007;8:685-701.
52. Emre N, Coleman R, Ding S. A chemical approach to stem cell biology. Curr Opin Chem Biol 2007;11:252-258.